Sylvain HAY

Corvera (YC W26, $6.2M raised) is the context layer for AI-native CPG brands. We help brands unlock the full potential of AI by making their unified data legible to any AI tool via MCP. With Corvera in place, brands can enable anyone in their organization to: - Rapidly deploy AI agents via tools such as Claude and ChatGPT - Build internal dashboards and apps using Cursor and Lovable - Automate workflows across the entire business, from category management to supply chain All in a secure, audit-logged, and access-controlled environment, without the need for a team of data engineers or AI specialists, in a simple plug-and-play solution. Were founded by Chris (2x Founder; ex-CEO at Better Nature; Forbes 30U30), Dirk (ex-Google Data & AI Lead), and Matthew (ex-Head of Product at Rosemark; Princeton MEng in CS). We’re backed by YC, firstminute capital, 6 Degrees Capital, 20VC, Rebel Fund, Duke Capital Partners, and more. Our mission is bold: to enable the next generation of unicorn CPG brands to be run by teams of less than 10 people. Our vision is even bolder: to be the system of intelligence for the $5.4T global CPG industry. Visit www.corvera.ai to learn more and schedule a demo!

WhiteLab Genomics is a TechBio company dedicated to unleashing the full power of genomic medicine with Artificial Intelligence. Founded in 2019 and backed by Y Combinator and the French Tech 2030 program, WhiteLab operates at the intersection of AI, computational biology, and structural biology, with offices in Paris, Boston, and Montréal. WhiteLab’s proprietary AI platform enables the rational design and optimization of delivery systems including viral and non-viral vectors, as well as RNA and DNA payloads. The company supports partners across a wide range of therapeutic areas, including but not limited to oncology, neurology, ophthalmology, auditory disorders, and rare diseases. WhiteLab’s mission is to unleash the potential of genomic medicine through advanced artificial intelligence, empowering scientists to design safer, more effective therapies from discovery through preclinical stages. WhiteLab collaborates with leading companies, including Sanofi, Cytiva and Debiopharm, and benefits from a strong network of top-tier academic partners such as the Brain Institute (ICM), the Vision Institute, the University of Massachusetts, and Genethon.

Corvera (YC W26, $6.2M raised) is the context layer for AI-native CPG brands. We help brands unlock the full potential of AI by making their unified data legible to any AI tool via MCP. With Corvera in place, brands can enable anyone in their organization to: - Rapidly deploy AI agents via tools such as Claude and ChatGPT - Build internal dashboards and apps using Cursor and Lovable - Automate workflows across the entire business, from category management to supply chain All in a secure, audit-logged, and access-controlled environment, without the need for a team of data engineers or AI specialists, in a simple plug-and-play solution. Were founded by Chris (2x Founder; ex-CEO at Better Nature; Forbes 30U30), Dirk (ex-Google Data & AI Lead), and Matthew (ex-Head of Product at Rosemark; Princeton MEng in CS). We’re backed by YC, firstminute capital, 6 Degrees Capital, 20VC, Rebel Fund, Duke Capital Partners, and more. Our mission is bold: to enable the next generation of unicorn CPG brands to be run by teams of less than 10 people. Our vision is even bolder: to be the system of intelligence for the $5.4T global CPG industry. Visit www.corvera.ai to learn more and schedule a demo!

WhiteLab Genomics is a TechBio company dedicated to unleashing the full power of genomic medicine with Artificial Intelligence. Founded in 2019 and backed by Y Combinator and the French Tech 2030 program, WhiteLab operates at the intersection of AI, computational biology, and structural biology, with offices in Paris, Boston, and Montréal. WhiteLab’s proprietary AI platform enables the rational design and optimization of delivery systems including viral and non-viral vectors, as well as RNA and DNA payloads. The company supports partners across a wide range of therapeutic areas, including but not limited to oncology, neurology, ophthalmology, auditory disorders, and rare diseases. WhiteLab’s mission is to unleash the potential of genomic medicine through advanced artificial intelligence, empowering scientists to design safer, more effective therapies from discovery through preclinical stages. WhiteLab collaborates with leading companies, including Sanofi, Cytiva and Debiopharm, and benefits from a strong network of top-tier academic partners such as the Brain Institute (ICM), the Vision Institute, the University of Massachusetts, and Genethon.